Curriculum · Cardiovascular and Hypertension
Prosthetic heart valves: bioprosthetic versus mechanical
What it is
There are two kinds of prosthetic heart valve, and the choice between them is a single trade: anticoagulation against durability.
- Bioprosthetic valve: usually does not require anticoagulation. Durability is 10-15 years, and less in dialysis patients and in the young.
- Mechanical valve: requires anticoagulation. Durability is indefinite.
So the young person, in whom a bioprosthetic valve lasts least, is the one who most needs a mechanical valve, and with it anticoagulation.
How it is treated
A bioprosthetic valve is chosen for a chronic bleeding problem, a life expectancy under 5 to 10 years, pregnancy, or patient preference about anticoagulation. A mechanical valve is chosen for everything else.
What can go wrong
Infective endocarditis is the risk that follows the valve. Prosthetic heart valves sit among the cardiac risk factors for IE next to acquired valvular disease and congenital heart defects, and among the predisposing factors for bacterial endocarditis next to dental procedures that cause bleeding, oral and upper respiratory tract surgery, genitourinary surgery, catheters in the right heart, pressure-monitoring catheters and IV drug use.
Which organism it is depends on how long the valve has been in. Staphylococcus epidermidis is the organism under 3 months, together with peripheral venous catheters. Staphylococcus aureus, the most common cause of acute IE, is the organism over 3 months, together with people who inject drugs and patients with pacemakers or ICDs.
Because of this, TEE is recommended in patients with prosthetic valves rather than TTE alone, and a new partial dehiscence of a prosthetic valve is evidence of endocardial involvement in the modified Duke criteria. Those criteria categorize the diagnostic likelihood of IE as definite or possible, and definite IE is any of:
- 2 or more major criteria
- 1 or more major criterion plus 3 or more minor criteria
- 5 or more minor criteria
The items themselves are held by BE TIMER, and the first two are major criteria: blood culture positive, and echocardiographic evidence of endocardial involvement. The other five are minor criteria: temperature above 38 C, immunological phenomena such as Osler's nodes and Roth spots, microbiological evidence, embolic phenomenon, and risk factors such as a congenital heart condition or IV drug use.
The other price of a mechanical valve is on the blood film: schistocytes, that is fragmented RBCs or helmet cells, appear with mechanical valves under MAHA, alongside DIC, TTP and HUS.